Related Experiment Video
Updated: Jun 10, 2026
06:08
Transcranial Pulse Stimulation for Alzheimer's Patients
Published on: April 4, 2025
[Caring for patients with Alzheimer's disease]
1Faculty of Humanities and Sciences, Kobegakuin University, Kobe, Hyogo, Japan.
Brain and Nerve = Shinkei Kenkyu No Shinpo
|August 3, 2010
Summary
Caring for Alzheimer disease patients involves therapeutic and compensatory care to maintain optimal functioning. Caregivers need skills and support to manage cognitive and behavioral impairments, preventing patient decline.
Area of Science:
- Gerontology
- Rehabilitation Medicine
- Neuroscience
Context:
- Alzheimer disease (AD) significantly impacts cognitive functions and behaviors.
- Optimal functioning in individuals with disabilities is supported by therapeutic and compensatory care.
- The International Classification of Functioning, Disability and Health (ICF) framework defines functioning across body, activity, and participation levels.
Purpose:
- To define and differentiate therapeutic and compensatory care strategies.
- To highlight the importance of assessing Alzheimer disease-related impairments.
- To emphasize the role of compensatory care in managing cognitive dysfunction and behavioral issues in AD.
Summary:
- Caring encompasses therapeutic care (restoring body functions) and compensatory care (enhancing activity and participation).
- Alzheimer disease necessitates systematic assessment of cognitive and behavioral impairments.
- Compensatory care is crucial for AD due to limited data on cognitive training efficacy.
- Caregiver training in managing behavioral problems and preventing overburdening is vital for patient outcomes.
Impact:
- Provides a framework for understanding and implementing effective care strategies for Alzheimer disease.
- Underscores the critical need for caregiver education and support systems.
- Contributes to improving the quality of life and functional outcomes for individuals with Alzheimer disease and their caregivers.
Related Concept Videos
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...